Patient satisfaction and acceptance of their totally implanted central venous catheter: a French prospective multicenter study.
Fiche publication
Date publication
septembre 2017
Journal
The journal of vascular access
Auteurs
Membres identifiés du Cancéropôle Est :
Dr RANGEARD Olivier
Tous les auteurs :
Marcy PY, Schiappa R, Ferrero JM, Dahlet C, Brenet O, Yazbec G, Dubois PY, Salm B, Fouche Y, Mari V, Montastruc M, Lebrec N, Ancel B, Paillocher N, Dupoiron D, Rangeard O, Gal J, Ettaiche M, Chateau Y, Chamorey E
Lien Pubmed
Résumé
Most cancer patients require a totally implanted central venous catheter (TIVAD) for their treatment. In a previous study, we developed and validated a questionnaire dubbed QASICC (Questionnaire for Acceptance of, and Satisfaction with, Implanted Central Venous Catheter) assessing patient satisfaction with, and acceptance of, their TIVAD. In the present study, we conducted a large, prospective, multicenter study in cancer patients aimed to analyze factors that could influence patients' acceptance of, and satisfaction with, their device.
Mots clés
Administration, Intravenous, Adult, Aged, Antineoplastic Agents, administration & dosage, Catheterization, Central Venous, instrumentation, Catheters, Indwelling, Central Venous Catheters, Female, France, Humans, Male, Middle Aged, Neoplasms, diagnosis, Patient Acceptance of Health Care, Patient Satisfaction, Prospective Studies, Psychometrics, Quality of Life, Surveys and Questionnaires, Young Adult
Référence
J Vasc Access. 2017 09 11;18(5):390-395